|
JPH0329734A
(ja)
|
1989-06-20 |
1991-02-07 |
Kubota Corp |
ラベルプリンタ
|
|
CA2392490A1
(en)
|
1999-11-24 |
2001-05-31 |
Mcs Micro Carrier Systems Gmbh |
Polypeptides comprising multimers of nuclear localization signals or of protein transduction domains and their use for transferring molecules into cells
|
|
US20040003420A1
(en)
|
2000-11-10 |
2004-01-01 |
Ralf Kuhn |
Modified recombinase
|
|
US20050222030A1
(en)
|
2001-02-21 |
2005-10-06 |
Anthony Allison |
Modified annexin proteins and methods for preventing thrombosis
|
|
US20040115184A1
(en)
|
2001-02-27 |
2004-06-17 |
Smith Harold C |
Methods and compositions for modifying apolipoprotein b mrna editing
|
|
AU2002330714A1
(en)
|
2001-05-30 |
2003-01-02 |
Biomedical Center |
In silico screening for phenotype-associated expressed sequences
|
|
US7300829B2
(en)
|
2003-06-02 |
2007-11-27 |
Applied Materials, Inc. |
Low temperature process for TFT fabrication
|
|
WO2010132092A2
(en)
|
2009-05-12 |
2010-11-18 |
The Scripps Research Institute |
Cytidine deaminase fusions and related methods
|
|
US20110104787A1
(en)
|
2009-11-05 |
2011-05-05 |
President And Fellows Of Harvard College |
Fusion Peptides That Bind to and Modify Target Nucleic Acid Sequences
|
|
US20130011380A1
(en)
|
2009-12-18 |
2013-01-10 |
Blau Helen M |
Use of Cytidine Deaminase-Related Agents to Promote Demethylation and Cell Reprogramming
|
|
US20130109048A1
(en)
|
2010-07-09 |
2013-05-02 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Method for in-vitro monitoring of neuronal disorders and use thereof
|
|
EP2761006B1
(en)
|
2011-09-28 |
2016-12-14 |
Zera Intein Protein Solutions, S.L. |
Split inteins and uses thereof
|
|
CN103088008B
(zh)
|
2011-10-31 |
2014-08-20 |
中国科学院微生物研究所 |
胞苷脱氨酶及其编码基因和它们的应用
|
|
EP3241902B1
(en)
|
2012-05-25 |
2018-02-28 |
The Regents of The University of California |
Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
|
|
US20150017136A1
(en)
|
2013-07-15 |
2015-01-15 |
Cellectis |
Methods for engineering allogeneic and highly active t cell for immunotherapy
|
|
US9102936B2
(en)
|
2012-06-11 |
2015-08-11 |
Agilent Technologies, Inc. |
Method of adaptor-dimer subtraction using a CRISPR CAS6 protein
|
|
DK3431497T3
(da)
|
2012-06-27 |
2022-10-10 |
Univ Princeton |
Spaltede inteiner, konjugater og anvendelser deraf
|
|
EP3363902B1
(en)
|
2012-12-06 |
2019-11-27 |
Sigma Aldrich Co. LLC |
Crispr-based genome modification and regulation
|
|
DK2931898T3
(en)
|
2012-12-12 |
2016-06-20 |
Massachusetts Inst Technology |
CONSTRUCTION AND OPTIMIZATION OF SYSTEMS, PROCEDURES AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH FUNCTIONAL DOMAINS
|
|
US9234213B2
(en)
|
2013-03-15 |
2016-01-12 |
System Biosciences, Llc |
Compositions and methods directed to CRISPR/Cas genomic engineering systems
|
|
US20140273230A1
(en)
|
2013-03-15 |
2014-09-18 |
Sigma-Aldrich Co., Llc |
Crispr-based genome modification and regulation
|
|
PL3546572T3
(pl)
|
2013-05-13 |
2024-07-22 |
Cellectis |
Chimeryczny receptor antygenowy swoisty względem cd19 i jego zastosowania
|
|
WO2014186686A2
(en)
|
2013-05-17 |
2014-11-20 |
Two Blades Foundation |
Targeted mutagenesis and genome engineering in plants using rna-guided cas nucleases
|
|
US20140356956A1
(en)
|
2013-06-04 |
2014-12-04 |
President And Fellows Of Harvard College |
RNA-Guided Transcriptional Regulation
|
|
EP3004370B1
(en)
|
2013-06-05 |
2024-08-21 |
Duke University |
Rna-guided gene editing and gene regulation
|
|
JP2016528890A
(ja)
|
2013-07-09 |
2016-09-23 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
ＣＲＩＳＰＲ／Ｃａｓ系を用いるゲノム編集の治療用の使用
|
|
WO2015021426A1
(en)
|
2013-08-09 |
2015-02-12 |
Sage Labs, Inc. |
A crispr/cas system-based novel fusion protein and its application in genome editing
|
|
US9526784B2
(en)
|
2013-09-06 |
2016-12-27 |
President And Fellows Of Harvard College |
Delivery system for functional nucleases
|
|
US9388430B2
(en)
|
2013-09-06 |
2016-07-12 |
President And Fellows Of Harvard College |
Cas9-recombinase fusion proteins and uses thereof
|
|
US9994831B2
(en)
|
2013-12-12 |
2018-06-12 |
The Regents Of The University Of California |
Methods and compositions for modifying a single stranded target nucleic acid
|
|
AU2014361781B2
(en)
|
2013-12-12 |
2021-04-01 |
Massachusetts Institute Of Technology |
Delivery, use and therapeutic applications of the CRISPR -Cas systems and compositions for genome editing
|
|
US20150165054A1
(en)
|
2013-12-12 |
2015-06-18 |
President And Fellows Of Harvard College |
Methods for correcting caspase-9 point mutations
|
|
ES2918501T3
(es)
|
2013-12-19 |
2022-07-18 |
Novartis Ag |
Receptores de antígenos quiméricos de mesotelina humana y usos de los mismos
|
|
WO2015092024A2
(en)
|
2013-12-20 |
2015-06-25 |
Cellectis |
Method of engineering multi-input signal sensitive t cell for immunotherapy
|
|
SG11201609211VA
(en)
*
|
2014-03-05 |
2016-12-29 |
Nat Univ Corp Univ Kobe |
Genomic sequence modification method for specifically converting nucleic acid bases of targeted dna sequence, and molecular complex for use in same
|
|
EP3593812A3
(en)
|
2014-03-15 |
2020-05-27 |
Novartis AG |
Treatment of cancer using chimeric antigen receptor
|
|
WO2015191693A2
(en)
|
2014-06-10 |
2015-12-17 |
Massachusetts Institute Of Technology |
Method for gene editing
|
|
AU2015289644A1
(en)
|
2014-07-15 |
2017-02-02 |
Juno Therapeutics, Inc. |
Engineered cells for adoptive cell therapy
|
|
WO2016022363A2
(en)
*
|
2014-07-30 |
2016-02-11 |
President And Fellows Of Harvard College |
Cas9 proteins including ligand-dependent inteins
|
|
JP2017522893A
(ja)
|
2014-07-31 |
2017-08-17 |
セレクティスＣｅｌｌｅｃｔｉｓ |
Ｒｏｒ１特異的多重鎖キメラ抗原受容体
|
|
EP3633032A3
(en)
|
2014-08-28 |
2020-07-29 |
North Carolina State University |
Novel cas9 proteins and guiding features for dna targeting and genome editing
|
|
ES2753391T3
(es)
|
2014-10-14 |
2020-04-08 |
Halozyme Inc |
Composiciones de adenosina desaminasa 2 (ADA2), variantes de la misma y métodos de uso de las mismas
|
|
WO2016061368A1
(en)
|
2014-10-15 |
2016-04-21 |
The Children's Hospital Of Philadelphia |
Compositions and methods for treating b-lymphoid malignancies
|
|
US10258697B2
(en)
|
2014-10-29 |
2019-04-16 |
Massachusetts Eye And Ear Infirmary |
Efficient delivery of therapeutic molecules in vitro and in vivo
|
|
US10920215B2
(en)
|
2014-11-04 |
2021-02-16 |
National University Corporation Kobe University |
Method for modifying genome sequence to introduce specific mutation to targeted DNA sequence by base-removal reaction, and molecular complex used therein
|
|
MA40921A
(fr)
|
2014-11-05 |
2017-09-12 |
Abbvie Stemcentrx Llc |
Récepteurs antigéniques chimériques anti-cldn et procédés d'utilisation
|
|
US11072644B2
(en)
|
2014-11-12 |
2021-07-27 |
Allogene Therapeutics, Inc. |
Inhibitory chimeric antigen receptors
|
|
EA036379B1
(ru)
|
2014-12-12 |
2020-11-02 |
Блубёрд Био, Инк. |
Химерные антигенные рецепторы к bcma
|
|
US10676737B2
(en)
|
2014-12-17 |
2020-06-09 |
Proqr Therapeutics Ii B.V. |
Targeted RNA editing
|
|
WO2016112242A1
(en)
|
2015-01-08 |
2016-07-14 |
President And Fellows Of Harvard College |
Split cas9 proteins
|
|
MA41613A
(fr)
|
2015-02-23 |
2018-01-02 |
Abbvie Stemcentrx Llc |
Récepteurs antigéniques chimériques anti-dll3 et procédés d'utilisation desdits récepteurs
|
|
EP3265559B1
(en)
|
2015-03-03 |
2021-01-06 |
The General Hospital Corporation |
Engineered crispr-cas9 nucleases with altered pam specificity
|
|
KR20170137079A
(ko)
|
2015-03-11 |
2017-12-12 |
셀렉티스 |
그것들의 지속을 증가시키기 위한 동종이계 t 세포의 조작 및/또는 환자들 내로 이식 방법들
|
|
CN106011104B
(zh)
*
|
2015-05-21 |
2019-09-27 |
清华大学 |
利用拆分Cas系统进行基因编辑和表达调控方法
|
|
JP6949728B2
(ja)
|
2015-05-29 |
2021-10-13 |
ジュノー セラピューティクス インコーポレイテッド |
遺伝子操作された細胞における阻害相互作用を調節するための組成物および方法
|
|
US9790490B2
(en)
|
2015-06-18 |
2017-10-17 |
The Broad Institute Inc. |
CRISPR enzymes and systems
|
|
WO2016205759A1
(en)
*
|
2015-06-18 |
2016-12-22 |
The Broad Institute Inc. |
Engineering and optimization of systems, methods, enzymes and guide scaffolds of cas9 orthologs and variants for sequence manipulation
|
|
US11479793B2
(en)
|
2015-07-15 |
2022-10-25 |
Rutgers, The State University Of New Jersey |
Nuclease-independent targeted gene editing platform and uses thereof
|
|
US9512446B1
(en)
|
2015-08-28 |
2016-12-06 |
The General Hospital Corporation |
Engineered CRISPR-Cas9 nucleases
|
|
US20180258149A1
(en)
|
2015-09-17 |
2018-09-13 |
Novartis Ag |
Car t cell therapies with enhanced efficacy
|
|
WO2017048969A1
(en)
|
2015-09-17 |
2017-03-23 |
The Regents Of The University Of California |
Variant cas9 polypeptides comprising internal insertions
|
|
JP7109784B2
(ja)
|
2015-10-23 |
2022-08-01 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
遺伝子編集のための進化したＣａｓ９蛋白質
|
|
MX2018005618A
(es)
|
2015-11-05 |
2018-08-01 |
Juno Therapeutics Inc |
Receptores quimericos que contienen dominios inductores de traf y composiciones y metodos relacionados.
|
|
US11020429B2
(en)
|
2015-11-05 |
2021-06-01 |
Juno Therapeutics, Inc. |
Vectors and genetically engineered immune cells expressing metabolic pathway modulators and uses in adoptive cell therapy
|
|
CA2999649A1
(en)
|
2015-11-06 |
2017-05-11 |
Crispr Therapeutics Ag |
Materials and methods for treatment of glycogen storage disease type 1a
|
|
CA3006618A1
(en)
|
2015-12-01 |
2017-06-08 |
Crispr Therapeutics Ag |
Materials and methods for treatment of alpha-1 antitrypsin deficiency
|
|
ES2949163T3
(es)
|
2016-01-29 |
2023-09-26 |
Univ Princeton |
Inteínas divididas con actividad de corte y empalme excepcional
|
|
WO2017165862A1
(en)
|
2016-03-25 |
2017-09-28 |
Editas Medicine, Inc. |
Systems and methods for treating alpha 1-antitrypsin (a1at) deficiency
|
|
TWI773666B
(zh)
|
2016-03-30 |
2022-08-11 |
美商英特利亞醫療公司 |
Crispr/cas 組分之脂質奈米粒子調配物
|
|
WO2017180993A1
(en)
|
2016-04-14 |
2017-10-19 |
Bluebird Bio, Inc. |
Salvage chimeric antigen receptor systems
|
|
CN110382692A
(zh)
|
2016-04-19 |
2019-10-25 |
博德研究所 |
新型crispr酶以及系统
|
|
US20200263190A1
(en)
|
2016-04-19 |
2020-08-20 |
The Broad Institute, Inc. |
Novel crispr enzymes and systems
|
|
WO2018020323A2
(en)
|
2016-07-25 |
2018-02-01 |
Crispr Therapeutics Ag |
Materials and methods for treatment of fatty acid disorders
|
|
NZ750256A
(en)
|
2016-08-03 |
2026-02-27 |
Dipersio John F |
Gene editing of car-t cells for the treatment of t cell malignancies with chimeric antigen receptors
|
|
KR102547316B1
(ko)
|
2016-08-03 |
2023-06-23 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
아데노신 핵염기 편집제 및 그의 용도
|
|
US11661590B2
(en)
|
2016-08-09 |
2023-05-30 |
President And Fellows Of Harvard College |
Programmable CAS9-recombinase fusion proteins and uses thereof
|
|
WO2018035388A1
(en)
|
2016-08-17 |
2018-02-22 |
The Broad Institute, Inc. |
Novel crispr enzymes and systems
|
|
WO2018035503A1
(en)
|
2016-08-18 |
2018-02-22 |
The Regents Of The University Of California |
Crispr-cas genome engineering via a modular aav delivery system
|
|
US10941402B2
(en)
|
2016-09-01 |
2021-03-09 |
Proqr Therapeutics Ii B.V. |
Chemically modified single-stranded RNA-editing oligonucleotides
|
|
EP3526320A1
(en)
|
2016-10-14 |
2019-08-21 |
President and Fellows of Harvard College |
Aav delivery of nucleobase editors
|
|
KR20240005168A
(ko)
|
2016-11-04 |
2024-01-11 |
2세븐티 바이오, 인코포레이티드 |
항-bcma car t 세포 조성물
|
|
WO2018089664A1
(en)
|
2016-11-11 |
2018-05-17 |
The Regents Of The University Of California |
Variant rna-guided polypeptides and methods of use
|
|
CN107043779B
(zh)
|
2016-12-01 |
2020-05-12 |
中国农业科学院作物科学研究所 |
一种CRISPR/nCas9介导的定点碱基替换在植物中的应用
|
|
AU2017374044B2
(en)
|
2016-12-08 |
2023-11-30 |
Intellia Therapeutics, Inc. |
Modified guide RNAs
|
|
AU2017379073B2
(en)
|
2016-12-22 |
2023-12-14 |
Intellia Therapeutics, Inc. |
Compositions and methods for treating alpha-1 antitrypsin deficiency
|
|
EP3559223A1
(en)
|
2016-12-23 |
2019-10-30 |
President and Fellows of Harvard College |
Gene editing of pcsk9
|
|
WO2018119359A1
(en)
|
2016-12-23 |
2018-06-28 |
President And Fellows Of Harvard College |
Editing of ccr5 receptor gene to protect against hiv infection
|
|
WO2018129129A1
(en)
|
2017-01-05 |
2018-07-12 |
Rutgers, The State University Of New Jersey |
Targeted gene editing platform independent of dna double strand break and uses thereof
|
|
WO2018152197A1
(en)
|
2017-02-15 |
2018-08-23 |
Massachusetts Institute Of Technology |
Dna writers, molecular recorders and uses thereof
|
|
SG11201907870VA
(en)
|
2017-02-28 |
2019-09-27 |
Vor Biopharma Inc |
Compositions and methods for inhibition of lineage specific proteins
|
|
JP2020510439A
(ja)
|
2017-03-10 |
2020-04-09 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
シトシンからグアニンへの塩基編集因子
|
|
CA3057192A1
(en)
|
2017-03-23 |
2018-09-27 |
President And Fellows Of Harvard College |
Nucleobase editors comprising nucleic acid programmable dna binding proteins
|
|
CN106916852B
(zh)
|
2017-04-13 |
2020-12-04 |
上海科技大学 |
一种碱基编辑系统及其构建和应用方法
|
|
WO2018195545A2
(en)
|
2017-04-21 |
2018-10-25 |
The General Hospital Corporation |
Variants of cpf1 (cas12a) with altered pam specificity
|
|
EP3625342B1
(en)
|
2017-05-18 |
2022-08-24 |
The Broad Institute, Inc. |
Systems, methods, and compositions for targeted nucleic acid editing
|
|
WO2018213708A1
(en)
|
2017-05-18 |
2018-11-22 |
The Broad Institute, Inc. |
Systems, methods, and compositions for targeted nucleic acid editing
|
|
US20200172895A1
(en)
|
2017-05-25 |
2020-06-04 |
The General Hospital Corporation |
Using split deaminases to limit unwanted off-target base editor deamination
|
|
CA3065946A1
(en)
|
2017-06-05 |
2018-12-13 |
Research Institute At Nationwide Children's Hospital |
Enhanced modified viral capsid proteins
|
|
AU2018290843B2
(en)
|
2017-06-26 |
2025-04-24 |
Massachusetts Institute Of Technology |
CRISPR/Cas-adenine deaminase based compositions, systems, and methods for targeted nucleic acid editing
|
|
WO2019005886A1
(en)
|
2017-06-26 |
2019-01-03 |
The Broad Institute, Inc. |
CRISPR / CAS-CYTIDINE DEAMINASE COMPOSITIONS, SYSTEMS AND METHODS FOR TARGETED EDITING OF NUCLEIC ACIDS
|
|
US11168322B2
(en)
|
2017-06-30 |
2021-11-09 |
Arbor Biotechnologies, Inc. |
CRISPR RNA targeting enzymes and systems and uses thereof
|
|
WO2019023680A1
(en)
|
2017-07-28 |
2019-01-31 |
President And Fellows Of Harvard College |
METHODS AND COMPOSITIONS FOR EVOLUTION OF BASIC EDITORS USING PHAGE-ASSISTED CONTINUOUS EVOLUTION (PACE)
|
|
CN118530967A
(zh)
|
2017-08-23 |
2024-08-23 |
通用医疗公司 |
具有改变的PAM特异性的工程化的CRISPR-Cas9核酸酶
|
|
EP3676376B1
(en)
|
2017-08-30 |
2025-01-15 |
President and Fellows of Harvard College |
High efficiency base editors comprising gam
|
|
EP4389889A3
(en)
|
2017-10-06 |
2024-09-04 |
Oregon Health & Science University |
Compositions and methods for editing rna
|
|
KR20250107288A
(ko)
|
2017-10-16 |
2025-07-11 |
더 브로드 인스티튜트, 인코퍼레이티드 |
아데노신 염기 편집제의 용도
|
|
CN109957569B
(zh)
|
2017-12-22 |
2022-10-25 |
苏州齐禾生科生物科技有限公司 |
基于cpf1蛋白的碱基编辑系统和方法
|
|
WO2019183000A1
(en)
|
2018-03-19 |
2019-09-26 |
University Of Massachusetts |
Modified guide rnas for crispr genome editing
|
|
CN121555430A
(zh)
|
2018-05-11 |
2026-02-24 |
比姆医疗股份有限公司 |
使用可编程碱基编辑器系统取代病原性氨基酸的方法
|
|
JP7558929B2
(ja)
|
2018-05-11 |
2024-10-01 |
ビーム セラピューティクス インク． |
プログラム可能塩基エディターシステムを用いて病原性変異を抑制する方法
|
|
AU2019266327B2
(en)
|
2018-05-11 |
2025-11-06 |
Beam Therapeutics Inc. |
Methods of editing single nucleotide polymorphism using programmable base editor systems
|
|
EP3797160A1
(en)
|
2018-05-23 |
2021-03-31 |
The Broad Institute Inc. |
Base editors and uses thereof
|
|
AU2019316094B2
(en)
|
2018-08-03 |
2026-02-19 |
Beam Therapeutics Inc. |
Multi-effector nucleobase editors and methods of using same to modify a nucleic acid target sequence
|
|
EP3841203A4
(en)
|
2018-08-23 |
2022-11-02 |
The Broad Institute Inc. |
CAS9 VARIANTS WITH NON-CANONICAL PAM SPECIFICITIES AND THEIR USES
|
|
US11530245B2
(en)
|
2018-08-31 |
2022-12-20 |
Washington University |
Split intein mediated polymerization and production of mussel foot adhesive protein materials
|
|
KR20210055733A
(ko)
|
2018-09-07 |
2021-05-17 |
빔 테라퓨틱스, 인크. |
핵염기 편집 시스템을 전달하기 위한 조성물 및 방법
|
|
CN109295186B
(zh)
|
2018-09-30 |
2023-10-03 |
中山大学 |
一种基于全基因组测序检测腺嘌呤单碱基编辑系统脱靶效应的方法及其在基因编辑中的应用
|
|
AU2019360372B2
(en)
|
2018-10-15 |
2026-02-26 |
Fondazione Telethon |
Intein proteins and uses thereof
|
|
US20220023348A1
(en)
|
2018-11-28 |
2022-01-27 |
Forty Seven, Inc. |
Genetically modified hspcs resistant to ablation regime
|
|
US20220047637A1
(en)
|
2018-11-29 |
2022-02-17 |
Editas Medicine, Inc. |
Systems and methods for the treatment of hemoglobinopathies
|
|
US11667682B2
(en)
|
2018-12-13 |
2023-06-06 |
Washington University |
Split intein mediated protein polymerization for microbial production of materials
|
|
WO2020146627A1
(en)
|
2019-01-10 |
2020-07-16 |
California Institute Of Technology |
A synthetic system for tunable thresholding of protein signals
|
|
EP3918077A4
(en)
|
2019-01-31 |
2023-03-29 |
Beam Therapeutics, Inc. |
NUCLEOBASE EDITORS WITH REDUCED OFF-TARGET DEAMINATION AND METHODS OF USING THEM TO MODIFY A NUCLEOBASE TARGET SEQUENCE
|
|
KR20210121113A
(ko)
|
2019-01-31 |
2021-10-07 |
빔 테라퓨틱스, 인크. |
비-표적 탈아미노화가 감소된 핵염기 편집기 및 핵염기 편집기를 특성규명하기 위한 분석
|
|
US11946040B2
(en)
|
2019-02-04 |
2024-04-02 |
The General Hospital Corporation |
Adenine DNA base editor variants with reduced off-target RNA editing
|
|
US20220098593A1
(en)
|
2019-02-13 |
2022-03-31 |
Beam Therapeutics Inc. |
Splice acceptor site disruption of a disease-associated gene using adenosine deaminase base editors, including for the treatment of genetic disease
|
|
WO2020168122A1
(en)
|
2019-02-13 |
2020-08-20 |
Beam Therapeutics Inc. |
Modified immune cells having adenosine deaminase base editors for modifying a nucleobase in a target sequence
|
|
KR20210126680A
(ko)
|
2019-02-13 |
2021-10-20 |
빔 테라퓨틱스, 인크. |
알파-1 항트립신 결핍증을 치료하기 위한 조성물 및 방법
|
|
US20220235347A1
(en)
|
2019-02-13 |
2022-07-28 |
Beam Therapeutics Inc. |
Compositions and methods for treating hemoglobinopathies
|
|
AU2020223306A1
(en)
|
2019-02-13 |
2021-08-05 |
Beam Therapeutics Inc. |
Methods of editing a disease-associated gene using adenosine deaminase base editors, including for the treatment of genetic disease
|
|
KR20210139265A
(ko)
|
2019-02-13 |
2021-11-22 |
빔 테라퓨틱스, 인크. |
표적 서열에서 핵염기를 변형하기 위한 아데노신 데아미나제 염기 편집기 및 이의 사용 방법
|
|
US20220127594A1
(en)
|
2019-02-13 |
2022-04-28 |
Beam Therapeutics Inc. |
Compositions and methods for treating glycogen storage disease type 1a
|
|
KR102129377B1
(ko)
|
2019-02-21 |
2020-07-02 |
성균관대학교산학협력단 |
특정 특성이 발현된 단백질을 암호화하는 플라스미드를 선별하는 유도 플라스미드 디스플레이 시스템
|
|
US12473543B2
(en)
|
2019-04-17 |
2025-11-18 |
The Broad Institute, Inc. |
Adenine base editors with reduced off-target effects
|
|
WO2020231863A1
(en)
|
2019-05-10 |
2020-11-19 |
Beam Therapeutics Inc. |
Compositions and methods for treating hepatitis b
|
|
WO2020236982A1
(en)
|
2019-05-20 |
2020-11-26 |
The Broad Institute, Inc. |
Aav delivery of nucleobase editors
|
|
US20220387622A1
(en)
|
2019-05-21 |
2022-12-08 |
Beam Therapeutics Inc. |
Methods of editing a single nucleotide polymorphism using programmable base editor systems
|
|
WO2020252455A1
(en)
|
2019-06-13 |
2020-12-17 |
The General Hospital Corporation |
Engineered human-endogenous virus-like particles and methods of use thereof for delivery to cells
|
|
WO2021016075A1
(en)
|
2019-07-19 |
2021-01-28 |
Flagship Pioneering Innovations Vi, Llc |
Recombinase compositions and methods of use
|
|
AU2020322021A1
(en)
|
2019-07-30 |
2022-02-10 |
Pairwise Plants Services, Inc. |
Morphogenic regulators and methods of using the same
|
|
KR102258713B1
(ko)
|
2019-07-31 |
2021-05-31 |
한양대학교 산학협력단 |
사이토신 염기교정용 조성물 및 이의 용도
|
|
CA3152861A1
(en)
|
2019-08-29 |
2021-03-04 |
Beam Therapeutics Inc. |
Compositions and methods for editing a mutation to permit transcription or expression
|
|
WO2021042062A2
(en)
|
2019-08-30 |
2021-03-04 |
Joung J Keith |
Combinatorial adenine and cytosine dna base editors
|
|
CN114667149A
(zh)
|
2019-09-09 |
2022-06-24 |
比姆医疗股份有限公司 |
新型核碱基编辑器及其使用方法
|
|
JP7814052B2
(ja)
|
2019-09-17 |
2026-02-16 |
ラトガース，ザ ステート ユニバーシティ オブ ニュー ジャージー |
標的ゲノム修飾のための高度に効率的なｒｎａ－アプタマー動員媒介性ｄｎａ塩基エディターおよびそれらの使用
|
|
US20220372496A1
(en)
|
2019-09-24 |
2022-11-24 |
MVRIX Co., Ltd. |
Nano-perforator having improved anti-viral activity
|
|
EP4034138A4
(en)
|
2019-09-27 |
2024-07-31 |
Beam Therapeutics, Inc. |
COMPOSITIONS AND METHODS FOR THE TREATMENT OF LIQUID CANCERS
|
|
US11591607B2
(en)
|
2019-10-24 |
2023-02-28 |
Pairwise Plants Services, Inc. |
Optimized CRISPR-Cas nucleases and base editors and methods of use thereof
|
|
KR20220110739A
(ko)
|
2019-10-30 |
2022-08-09 |
페어와이즈 플랜츠 서비시즈, 인크. |
유형 v crispr-cas 염기 편집제 및 그의 사용 방법
|
|
CA3162499A1
(en)
|
2019-11-22 |
2021-05-27 |
Flagship Pioneering Innovations Vi, Llc |
Recombinase compositions and methods of use
|
|
US20230086199A1
(en)
|
2019-11-26 |
2023-03-23 |
The Broad Institute, Inc. |
Systems and methods for evaluating cas9-independent off-target editing of nucleic acids
|
|
GB201918693D0
(en)
|
2019-12-18 |
2020-01-29 |
Univ Southampton |
Peptide
|
|
WO2021158921A2
(en)
|
2020-02-05 |
2021-08-12 |
The Broad Institute, Inc. |
Adenine base editors and uses thereof
|
|
JP2023516692A
(ja)
|
2020-03-04 |
2023-04-20 |
フラッグシップ パイオニアリング イノベーションズ シックス，エルエルシー |
ゲノムを調節するための方法及び組成物
|
|
CA3174483A1
(en)
|
2020-03-04 |
2021-09-10 |
Flagship Pioneering Innovations Vi, Llc |
Improved methods and compositions for modulating a genome
|
|
IL296024A
(en)
|
2020-03-04 |
2022-10-01 |
Flagship Pioneering Innovations Vi Llc |
Methods and compositions for modulating a genome
|
|
AU2021232069A1
(en)
|
2020-03-05 |
2022-11-03 |
Flagship Pioneering Innovations Vi, Llc |
Host defense suppressing methods and compositions for modulating a genome
|
|
AU2021236683A1
(en)
|
2020-03-19 |
2022-11-17 |
Intellia Therapeutics, Inc. |
Methods and compositions for directed genome editing
|
|
EP3885440A1
(en)
|
2020-03-26 |
2021-09-29 |
Splicebio, S.L. |
Split inteins and their uses
|
|
WO2021207651A2
(en)
|
2020-04-09 |
2021-10-14 |
Verve Therapeutics, Inc. |
Chemically modified guide rnas for genome editing with cas12b
|
|
WO2021209574A1
(en)
|
2020-04-15 |
2021-10-21 |
Fondazione Telethon |
Constructs comprising inteins
|
|
WO2021222318A1
(en)
|
2020-04-28 |
2021-11-04 |
The Broad Institute, Inc. |
Targeted base editing of the ush2a gene
|
|
EP4179079A1
(en)
|
2020-07-10 |
2023-05-17 |
Horizon Discovery Limited |
Method for producing genetically modified cells
|
|
JP2023534693A
(ja)
|
2020-07-15 |
2023-08-10 |
ライフエディット セラピューティクス，インコーポレイティド |
ウラシル安定化タンパク質並びにその活性断片及びバリアント並びに使用方法
|
|
EP4185600A4
(en)
|
2020-07-24 |
2024-12-04 |
The General Hospital Corporation |
Enhanced virus-like particles and methods of use thereof for delivery to cells
|
|
CA3192224A1
(en)
|
2020-09-11 |
2022-03-17 |
Jyun-Liang LIN |
Base editing enzymes
|
|
TWI910226B
(zh)
|
2020-09-11 |
2026-01-01 |
美商生命編輯治療學公司 |
Ｄｎａ修飾酶及活性片段，及其變異體與使用方法
|
|
US20230383277A1
(en)
|
2020-10-14 |
2023-11-30 |
Beam Therapeutics Inc. |
Compositions and methods for treating glycogen storage disease type 1a
|
|
IT202000028688A1
(it)
|
2020-11-27 |
2022-05-27 |
Consiglio Nazionale Ricerche |
Varianti della citidina deaminasi per l’editazione di basi
|
|
CA3207144A1
(en)
|
2021-01-05 |
2022-07-14 |
Horizon Discovery Limited |
Method for producing genetically modified cells
|
|
JP2024502348A
(ja)
|
2021-01-05 |
2024-01-18 |
ホライズン・ディスカバリー・リミテッド |
Ｔｒａｃｒ不含 Ｖ型Ｃａｓシステム用のガイドＲＮＡデザインおよび複合体
|
|
WO2022150372A1
(en)
|
2021-01-05 |
2022-07-14 |
Horizon Discovery Ltd. |
Guide rna designs and complexes for type v cas systems
|
|
EP4274897A4
(en)
|
2021-01-08 |
2025-03-05 |
The General Hospital Corporation |
GENOMEDITING APPROACHES TO THE TREATMENT OF SPINAL MUSCLE ATROPHY
|
|
WO2022178307A1
(en)
|
2021-02-19 |
2022-08-25 |
Beam Therapeutics Inc. |
Recombinant rabies viruses for gene therapy
|
|
CA3214494A1
(en)
|
2021-03-26 |
2022-09-29 |
Beam Therapeutics Inc. |
Adenosine deaminase variants and uses thereof
|
|
CN113813398B
(zh)
|
2021-04-23 |
2023-11-07 |
天津医科大学 |
一种向表面富含神经节苷脂的细胞递送重组蛋白质的方法
|
|
US20240327859A1
(en)
|
2021-07-02 |
2024-10-03 |
University Of Maryland, College Park |
Cytidine deaminases and methods of genome editing using the same
|
|
AU2022311013A1
(en)
|
2021-07-16 |
2024-02-08 |
President And Fellows Of Harvard College |
Context-specific adenine base editors and uses thereof
|
|
CN113480613B
(zh)
|
2021-08-04 |
2022-04-15 |
江南大学 |
一种自剪切蛋白标签、改造方法及其应用
|
|
CN113735941B
(zh)
|
2021-08-13 |
2024-01-30 |
江南大学 |
一种蛋白纯化方法及其应用
|
|
US20240352439A1
(en)
|
2021-09-03 |
2024-10-24 |
The University Of Chicago |
Polypeptides and methods for modifying nucleic acids
|
|
AU2022349449A1
(en)
|
2021-09-22 |
2024-04-18 |
Verve Therapeutics, Inc. |
Gene editing of pcsk9 or angptl3 and compositions and methods of using same for treatment of disease
|
|
WO2023047338A1
(en)
|
2021-09-24 |
2023-03-30 |
Crispr Therapeutics Ag |
PRODRUG INCORPORATED sgRNA SYNTHESIS
|
|
WO2023125814A1
(zh)
|
2021-12-29 |
2023-07-06 |
华东师范大学 |
腺嘌呤脱氨酶及其应用
|
|
CN119013310A
(zh)
|
2022-02-17 |
2024-11-22 |
正序(上海)生物科技有限公司 |
具有改善的编辑精确度的突变的胞嘧啶脱氨酶
|
|
CN117925585A
(zh)
|
2022-04-07 |
2024-04-26 |
尧唐(上海)生物科技有限公司 |
腺苷脱氨酶、碱基编辑器融合蛋白、碱基编辑器系统及用途
|
|
WO2023227669A2
(en)
|
2022-05-26 |
2023-11-30 |
UCB Biopharma SRL |
Novel nucleic acid-editing proteins
|
|
EP4540378A1
(en)
|
2022-06-20 |
2025-04-23 |
CRISPR Therapeutics AG |
Base editing proteins and uses thereof
|
|
AU2023288909A1
(en)
|
2022-06-23 |
2025-01-09 |
Basf Agricultural Solutions Us Llc |
Diversifying base editing
|
|
CA3263821A1
(en)
|
2022-08-16 |
2024-02-22 |
The Broad Institute, Inc. |
ADVANCED CYTOSIN DESAMINASE AND DNA EDITING METHODS USING IT
|
|
CN119998447A
(zh)
|
2022-09-23 |
2025-05-13 |
基础科学研究院 |
新型腺嘌呤脱氨酶变体及使用其进行碱基编辑的方法
|
|
CA3267375A1
(en)
|
2022-09-26 |
2024-04-04 |
Beam Therapeutics Inc. |
SYNTHETIC POLYPEPTIDES AND THEIR USES
|
|
WO2024179426A2
(en)
|
2023-02-28 |
2024-09-06 |
Accuredit Therapeutics (Suzhou) Co., Ltd. |
Deaminases for use in base editing
|
|
WO2024226156A1
(en)
|
2023-04-27 |
2024-10-31 |
University Of Massachusetts |
Cas-embedded cytidine deaminase ribonucleoprotein complexes having improved base editing specificity and efficiency
|
|
WO2024227047A2
(en)
|
2023-04-28 |
2024-10-31 |
Beam Therapeutics Inc. |
Modified guide rna
|
|
CN121889499A
(zh)
|
2023-06-15 |
2026-04-17 |
比姆医疗股份有限公司 |
用于治疗α1-抗胰蛋白酶缺乏症的方法和组合物
|
|
CN117965505A
(zh)
|
2023-06-28 |
2024-05-03 |
微光基因(苏州)有限公司 |
工程化的腺苷脱氨酶及碱基编辑器
|